Technical Analysis for GALT - Galectin Therapeutics Inc.

Grade Last Price % Change Price Change
B 2.14 3.88% 0.08
GALT closed up 3.88 percent on Monday, March 18, 2024, on 2.32 times normal volume.
Earnings due: Mar 28
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Touch Strength 0.00%
MACD Bullish Signal Line Cross Bullish 3.88%
Pocket Pivot Bullish Swing Setup 3.88%
Gapped Up Strength 3.88%
MACD Bearish Signal Line Cross Bearish 8.08%
NR7 Range Contraction 8.08%
Narrow Range Bar Range Contraction 8.08%
Inside Day Range Contraction 8.08%
Inside Day Range Contraction 8.08%

   Recent Intraday Alerts

Alert Time
Upper Bollinger Band Resistance about 13 hours ago
2x Volume Pace about 14 hours ago
Possible Pocket Pivot about 14 hours ago
Up 5% about 14 hours ago
Up 1 ATR about 14 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Galectin Therapeutics Inc., a development stage company, engages in the development of therapies for cancer and fibrotic disease. Its lead product candidates include GR-MD-02, a complex polysaccharide polymer for the treatment of liver fibrosis and fatty liver disease for which the company intends to initiate a Phase I clinical trial in patients with non-alcoholic steatohepatitis; and GM-CT-01, a linear polysaccharide polymer comprising mannose and galactose that is in a Phase I/II clinical trial in Europe as a combination therapy with a tumor vaccine in patients with advanced melanoma. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Cancer Alcohol Tumor Melanoma Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Liver Disease Therapies For Cancer Fibrotic Disease Lectins Liver Fibrosis Combination Therapy Galectin Lactose Fatty Liver Fatty Liver Disease Galectin 3 Galecto Biotech

Is GALT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.28
52 Week Low 1.28
Average Volume 65,502
200-Day Moving Average 1.77
50-Day Moving Average 1.83
20-Day Moving Average 1.96
10-Day Moving Average 2.04
Average True Range 0.11
RSI (14) 69.04
ADX 31.28
+DI 25.65
-DI 9.16
Chandelier Exit (Long, 3 ATRs) 1.85
Chandelier Exit (Short, 3 ATRs) 2.02
Upper Bollinger Bands 2.15
Lower Bollinger Band 1.78
Percent B (%b) 0.97
BandWidth 19.05
MACD Line 0.07
MACD Signal Line 0.07
MACD Histogram 0.0062
Fundamentals Value
Market Cap 132.36 Million
Num Shares 61.8 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -2.82
Price-to-Sales 0.00
Price-to-Book 207.70
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.38
Resistance 3 (R3) 2.36 2.27 2.34
Resistance 2 (R2) 2.27 2.21 2.28 2.33
Resistance 1 (R1) 2.20 2.17 2.24 2.22 2.31
Pivot Point 2.11 2.11 2.12 2.12 2.11
Support 1 (S1) 2.04 2.05 2.08 2.06 1.97
Support 2 (S2) 1.95 2.01 1.96 1.95
Support 3 (S3) 1.88 1.95 1.94
Support 4 (S4) 1.90